psoralidin
CAS: 18642-23-4
Ref. 3D-FP73918
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar | ||
| 250mg | A consultar |
Información del producto
- 3,9-Dihydroxy-2-(3-methyl-2-buten-1-yl)-6H-benzofuro[3,2-c][1]benzopyran-6-one
- 3,9-Dihydroxy-2-(3-methyl-2-butenyl)-6H-benzofuro(3,2-c)(1)benzopyran-6-one
- 3,9-Dihydroxy-2-(3-methylbut-2-enyl)-[1]benzofuro[3,2-c]chromen-6-one
- 3,9-dihydroxy-2-(3-methylbut-2-en-1-yl)-6H-[1]benzofuro[3,2-c]chromen-6-one
- 3-Benzofurancarboxylic acid, 2-[2,4-dihydroxy-5-(3-methyl-2-butenyl)phenyl]-6-hydroxy-, δ-lactone
- 6H-Benzofuro(3,2-c)(1)benzopyran-6-one, 3,9-dihydroxy-2-(3-methyl-2-butenyl)-
- 6H-Benzofuro[3,2-c][1]benzopyran-6-one, 3,9-dihydroxy-2-(3-methyl-2-buten-1-yl)-
Psoralidin is a pharmacological agent that induces apoptosis in cancer cells. It binds to the response element of the pro-apoptotic gene, PUMA, and causes the activation of several proteins involved in the apoptosis pathway. It has been shown to successfully induce cell death in HL-60 cells and murine hepatoma cells. Psoralidin is also able to inhibit cancer cell proliferation by suppressing the expression of oncogenes such as MMP-2, MMP-9, and COX-2. The mechanism by which psoralidin induces apoptosis is not yet fully understood but may be due to its ability to induce endoplasmic reticulum stress or activate caspases.
Propiedades químicas
Consulta técnica sobre: 3D-FP73918 psoralidin
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
